PURPOSE: The purpose of this study was to determine the impact of end-stage renal disease (ESRD) on the outcome of patients undergoing lower extremity (LE) amputation. METHODS: Hospital charts and vascular surgery registry data were reviewed for all patients who underwent LE amputation over a consecutive 56-month period. The results of 84 patients with ESRD (137 amputations) were compared with 375 patients (442 amputations) without ESRD. RESULTS: Hospital mortality rate was significantly greater in patients with ESRD than patients without ESRD, 24% versus 7% (p = 0.001). Patients with ESRD undergoing minor amputations had mortality rates three times greater than patients without ESRD undergoing major LE amputations. In patients with ESRD requiring bilateral or unilateral above-knee amputation hospital mortality rates were 43% and 38%, respectively. In addition, patients with ESRD were seven times more likely to undergo bilateral amputation than patients without ESRD over a mean follow-up period of 17 months. No kidney transplant patients died after amputation. CONCLUSION: ESRD has a profound negative impact on morbidity, mortality, and survival rates after LE amputation. Attempts at prevention of amputation with aggressive foot care and patient education in this high-risk group should be the focus of therapy.
PURPOSE: The purpose of this study was to determine the impact of end-stage renal disease (ESRD) on the outcome of patients undergoing lower extremity (LE) amputation. METHODS: Hospital charts and vascular surgery registry data were reviewed for all patients who underwent LE amputation over a consecutive 56-month period. The results of 84 patients with ESRD (137 amputations) were compared with 375 patients (442 amputations) without ESRD. RESULTS: Hospital mortality rate was significantly greater in patients with ESRD than patients without ESRD, 24% versus 7% (p = 0.001). Patients with ESRD undergoing minor amputations had mortality rates three times greater than patients without ESRD undergoing major LE amputations. In patients with ESRD requiring bilateral or unilateral above-knee amputation hospital mortality rates were 43% and 38%, respectively. In addition, patients with ESRD were seven times more likely to undergo bilateral amputation than patients without ESRD over a mean follow-up period of 17 months. No kidney transplant patients died after amputation. CONCLUSION:ESRD has a profound negative impact on morbidity, mortality, and survival rates after LE amputation. Attempts at prevention of amputation with aggressive foot care and patient education in this high-risk group should be the focus of therapy.
Authors: Tejas P Singh; Joseph V Moxon; Michael T Meehan; Rhondda Jones; Yvonne Cadet-James; Jonathan Golledge Journal: BMC Endocr Disord Date: 2021-05-21 Impact factor: 2.763
Authors: Catherine R Butler; Margaret L Schwarze; Ronit Katz; Susan M Hailpern; William Kreuter; Yoshio N Hall; Maria E Montez Rath; Ann M O'Hare Journal: J Am Soc Nephrol Date: 2019-02-19 Impact factor: 10.121
Authors: H Ishii; Y Kumada; H Takahashi; T Toriyama; T Aoyama; M Tanaka; D Yoshikawa; M Hayashi; H Kasuga; Y Yasuda; S Maruyama; T Matsubara; S Matsuo; T Murohara Journal: Diabetologia Date: 2012-05 Impact factor: 10.122
Authors: Lawrence A Lavery; Nathan A Hunt; Javier Lafontaine; Cory L Baxter; Agbor Ndip; Andrew J M Boulton Journal: Diabetes Care Date: 2010-04-27 Impact factor: 19.112
Authors: Roland Assi; Yorg Al Azzi; Clinton D Protack; Willis T Williams; Michael R Hall; Daniel J Wong; Daniel Y Lu; Penny Vasilas; Alan Dardik Journal: N Am J Med Sci Date: 2014-07
Authors: Michelle R Kaminski; Anita Raspovic; Lawrence P McMahon; Katrina A Lambert; Bircan Erbas; Peter F Mount; Peter G Kerr; Karl B Landorf Journal: BMC Nephrol Date: 2017-09-08 Impact factor: 2.388